Newsletter
Earnings
Interviews
Transcripts
×
Menu
Home
Earnings
Interviews
Transcripts
IPO
Tech
Health Care
AstraZeneca’s Q2 results beat market expectations
July 25, 2019
What to expect from AbbVie Q2 earnings
July 24, 2019
Earnings preview: Celgene deal in focus as Bristol-Myers prepares for Q2 results
July 24, 2019
Boston Scientific Q2 profit dips 72% but beats estimates
July 24, 2019
Earnings: Alexion Pharma Q2 results top expectations; raises FY19 guidance
July 24, 2019
Edwards Lifesciences stock surges on Q2 earnings beat, raises 2019 outlook
July 23, 2019
Aethlon Medical earnings preview: Cash crunch at its peak ahead of Q4 results
June 28, 2019
Pfizer secures FDA approval for oncology biosimilar Zirabev; stock gains
June 28, 2019
What the future holds for generic drug industry
June 25, 2019
M&A alert: AbbVie agrees to acquire Allergan for $63 billion
June 25, 2019
Bristol-Myers lets go of psoriasis drug to save Celgene merger; stock falls
June 24, 2019
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
June 22, 2019
Ocular Therapeutix gains after FDA approves eye drug for additional indication
June 21, 2019
Chevron Phillips Chemical is looking to acquire Nova Chemicals
June 21, 2019
Earnings: Canopy Growth posts big Q4 miss, but investors remain stoic
June 21, 2019
MediWound stock plunges to a record low on gloomy future
June 18, 2019
Pharma stocks: Merck is on a buying spree
June 18, 2019
Earnings preview: Will Canopy Growth post upbeat Q4 2019 results?
June 17, 2019
Pfizer boosts oncology portfolio with $10-Bil acquisition of Array Biopharma
June 17, 2019
Abbvie’s oncology push makes it an attractive stock
June 13, 2019
HEXO Corp (HEXO) disappoints in Q3
June 12, 2019
Posts pagination
« Previous
1
…
88
89
90
91
92
…
103
Next »
Top